3[2]Bennett JM.World Health organization classification of the acate leukemias and myelodysplastic syndrome[J].Int Hematol,2000,72(7):131-133.
4Takashima H,Eguchi K,Origuchi T,et al.Collagen disease complicated with mye-Lodysplastic syndrome-report of three cases[J].Ryumachi,1994,34(1):48.
5Diebold L,Rauh G,Jager K,et al.Bone marrow pathology in relapsingpoly chondyitis:high frequency of myelodysplastic syndromes[J].Br J Haematol,1995,89:820-830.
6Enyight H,Jacob HS,Vercellotti G,et al.Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes:response to immunosuppressive therapy[J].Br J Haematol,1995,91:403-408.
7Pnilippe B,Coudere LJ,Droz D,et al.Systemic vasculitis and myelodysplastic syndromes.A report of two cases[J].Arthritis Rheum,1997,40:179-182.
8Reuss-Borst MA,Pawelec G,Seal JG,et al.Sweet's syndrome associated with myelodysplasia:possible role of cytokines in the pathogenesis of the disease[J].Br J Haematol,1993,84:356-358.
9Shimaoto Y,Narisawa Y,Suga K,et al.Relationship between autoantibody and dermatosis in myelodysplastic syndrome[J].Hematologia Budap,1993,25(4):253.
10Jonasova A,Neuwirtova R,Cermak J,et al.Cyclosporin A therapy in hypoplastic MDS patients and certain refractor anaemias without hypoplastic bone marrow[J].Br J Haematol,1998,100:304-309.
